Navigation Links
Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia
Date:9/11/2008

nt of fibromyalgia and the timing of the release of clinical study results and the submission of a New Drug Application to the FDA. These forward-looking statements are based on the company's current expectations and inherently involve significant risks and uncertainties. Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the clinical trials of Jazz Pharmaceuticals' JZP-6 product candidate, including the risk that clinical trial results may require Jazz Pharmaceuticals to discontinue its development, risks related to our reliance on third parties to conduct the clinical trials for our product candidates, and risks that regulatory filings may not be made, or may be delayed, and that products may not be approved for marketing by regulatory authorities. These and other risk factors are discussed under "Risk Factors" in the Quarterly Report on Form 10-Q for the quarter ended June 30, 2008 filed by Jazz Pharmaceuticals with the Securities and Exchange Commission on August 8, 2008. Jazz Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
2. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
3. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
4. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
5. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
7. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
8. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
9. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
10. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
11. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... et SAN DIEGO , ... Ltd. (ci-après désignée Daiichi Sankyo) (TSE : 4568) et ... la conclusion d,un accord de fusion définitif en ... totalité des actions ordinaires en circulation d,Ambit Biosciences ... le biais d,une offre publique d,achat qui sera ...
(Date:9/29/2014)... Pharmacists have an important role in ... good clinical trials practices. The Hematology/Oncology Pharmacy Association ... Practice Standards, the first of its kind that ... pharmacists and institutions that conduct clinical trials. The ... the critical role of the pharmacist in the ...
(Date:9/29/2014)... -- Bob Pack, who lost his two young children to ... Association to immediately cease airing a television ad from ... News called "shamelessly deceptive" and of which the LA ... about the measure is wrong." The ... doctors check California,s existing statewide ...
Breaking Medicine Technology:Daiichi Sankyo va acquérir Ambit Biosciences 2Daiichi Sankyo va acquérir Ambit Biosciences 3Daiichi Sankyo va acquérir Ambit Biosciences 4Daiichi Sankyo va acquérir Ambit Biosciences 5Daiichi Sankyo va acquérir Ambit Biosciences 6Daiichi Sankyo va acquérir Ambit Biosciences 7Daiichi Sankyo va acquérir Ambit Biosciences 8Daiichi Sankyo va acquérir Ambit Biosciences 9HOPA Introduces First Investigational Drug Service Best Practice Standards For Institutions And Infusion Clinics 2HOPA Introduces First Investigational Drug Service Best Practice Standards For Institutions And Infusion Clinics 3Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 2Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 3Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 4Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 5
... Cumberland Pharmaceuticals Inc.(Nasdaq: CPIX ) today announced ... review of the supplemental new drug application (sNDA) for the ... non-acetaminophen acute liver failure. The review has been extended by ... Act (PDUFA) goal date in December 2010. ...
... Aug. 20 Environmental Tectonics Corporation,s (OTC Bulletin ... ,Company") Biomedical Systems, a worldwide leader in the ... confirmed that it has received FDA 510-k clearance ... for "Operating System for Control And Recording." This ...
Cached Medicine Technology:Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 2Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 3ETC Biomedical Systems Offers New FDA Approved Hyperbaric Oxygen Therapy (HBOT) Medical Device 2ETC Biomedical Systems Offers New FDA Approved Hyperbaric Oxygen Therapy (HBOT) Medical Device 3ETC Biomedical Systems Offers New FDA Approved Hyperbaric Oxygen Therapy (HBOT) Medical Device 4
(Date:9/30/2014)... 2014 Bibliomotion is proud to ... Leadership for the Complex Social Age by Frank Guglielmo ... In the book, the authors apply their leadership coaching experience ... view the conversations, actions, and behaviors that leaders must adopt ... Click here to read a review of The Social ...
(Date:9/30/2014)... Pyramid Analytics, worldwide leader in ... Department of Veterans Affairs has selected Pyramid ... User Business Intelligence platform. This partnership will enable ... by enabling more than 30,000 users with insights ... analytics and reporting capabilities. , The strategic selection ...
(Date:9/30/2014)... RBS Reputation Management is reported to have started a ... , The service name may surprise as well as confuse ... odd name, a management professional said, “This may be your ... have named the service ‘Remove Your Name’ because it would ... all those posts which light their name in bad sense.” ...
(Date:9/30/2014)... Toronto, Ontario, Canada (PRWEB) September 30, 2014 ... of diagnostic imaging services based in San Juan, ... and automate their workflows. , Nivia Souffront, ... impact to their facility. “We are excited to ... able to provide better patient care and physician ...
(Date:9/30/2014)... A trailblazer at heart, Dr. Scott Katzman stays versed in ... spine repairs. His newest appreciation has been for the ... he has implanted the Mobi-C Artificial Disc by ... mimic normal human disc motion. Dr. Katzman goes on to ... an exceptional replacement device for failing fusions. Patients that have ...
Breaking Medicine News(10 mins):Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 3Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 4Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 5Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 6Health News:U.S. Department of Veterans Affairs Takes Its Analytic Capabilities to the Next Level with BI Office from Pyramid Analytics 2Health News:RBS Reputation Management Announces A New Service ‘Remove Your Name’ 2Health News:Signet Puerto Rico Leverages PowerServer RIS/PACS/PM™ to Improve Patient Care, Cut Costs 2
... Hospital surgeons found that a carefully-selected surgical care check ... nearly 50 percent. Smoking cessation at least ... to skin closure, and using clippers over razors to shave ... reduced infection rates, according to the study published in the ...
... TUESDAY, Oct. 25 (HealthDay News) -- The most widely used ... percent effective in healthy adults, new research indicates. That ... about 90 percent of flu shots in this country, according ... The Lancet Infectious Diseases . The less common live ...
... just for making freckles and tans. Melanocytes absorb ultraviolet light, ... They also are the cells that go haywire in melanoma, ... albinism. Naturally, researchers would love to study melanocytes in ... skin don,t grow very well in the lab. Now, researchers ...
... the more than 10,000 substances that may be added ... a trade association without review by the U.S. Food ... by the Pew Health Group. , The report, published ... Food Science and Food Safety , illustrates potential problems ...
... Stanford, CA -- Calling for more rapid innovation in ... program of the Thiel Foundation, Breakout Labs. Speaking ... Association of Stanford Entrepreneurial Students, Thiel announced that Breakout ... way early-stage science and technology research is funded by ...
... in the Department of Radiation Oncology at Thomas Jefferson ... named an "Educator of the Year" by the Association ... the annual Educator of the Year Award to recognize ... from all radiation oncology programs were given the opportunity ...
Cached Medicine News:Health News:Thomas Jefferson University Hospital cuts Whipple procedure wound infections in half with new measures 2Health News:Flu Vaccine Isn't Foolproof 2Health News:Flu Vaccine Isn't Foolproof 3Health News:Lab-made skin cells will aid transplantation, cancer, drug discovery research 2Health News:Food chemical regulations rely heavily on industry self-policing and lack transparency 2Health News:Peter Thiel announces Breakout Labs to energize innovation 2Health News:Jefferson physician named an 'Educator of the Year' by the Assocociation of Residents in Radiation Oncology 2
... to add individual components for individual indications. ... indications. Made of an innovative composite plastic ... only much lighter. This means it's easier ... comfortable for the patient. ,Comes pre-assembled, packaged ...
... (iopamidol injection) is a safe and effective ... clinical experience since 1986. Worldwide, more ... been administered. Indicated for a wide ... flexibility by providing a wide range of ...
... agent FDA-approved for administration by power injector, ... contrast media for MR imaging of the ... convenient packaging options for just the right ... delivery. You can trust OptiMARK® for ...
... contrast agent approved for sale in the ... the Amersham Health portfolio to include an ... aids in the detection, localization, characterization, and ... within minutes of injection, and additional scans ...
Medicine Products: